Abdominal fat focus
Focus on visceral abdominal fat
A more focused approach to body composition.
Frustrated by stubborn abdominal fat despite your efforts? Tesamorelin stimulates the body’s growth-hormone pathway and is FDA-approved to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. Other uses are not FDA-approved.

Focus on visceral abdominal fat
Look beyond scale weight
Build around measurable follow-up
People exploring a provider-guided approach focused specifically on abdominal fat and body composition.
Unlike general weight-loss medications, Tesamorelin is discussed around visceral abdominal fat and the growth-hormone pathway.
This drug is compounded by a licensed pharmacy in accordance with Section 503A of the Federal Food, Drug & Cosmetic Act and may be dispensed only under a patient-specific prescription issued by a licensed practitioner following a medical evaluation. FDA does not review or approve compounded medications for safety, effectiveness, or quality. Individual results may vary. Actual product packaging may differ from images shown.